Comments on: Vermont Gets Grilled Over Its Data Mining Law http://www.pharmalot.com/2009/10/vermont-gets-grilled-over-its-data-mining-law/ News, Comment and Conversation Fri, 10 Feb 2012 22:38:19 +0000 http://wordpress.org/?v=2.6.2 By: atlex http://www.pharmalot.com/2009/10/vermont-gets-grilled-over-its-data-mining-law/#comment-437481 atlex Thu, 15 Oct 2009 18:08:20 +0000 http://www.pharmalot.com/?p=19054#comment-437481 Or, like doctors who no longer take Medicare or Medicaid patients because the reimbursement (ie, sales) return makes them fiscally unviable. Or, like doctors who no longer take Medicare or Medicaid patients because the reimbursement (ie, sales) return makes them fiscally unviable.

]]> By: Doc http://www.pharmalot.com/2009/10/vermont-gets-grilled-over-its-data-mining-law/#comment-437460 Doc Thu, 15 Oct 2009 16:30:56 +0000 http://www.pharmalot.com/?p=19054#comment-437460 Atlex, No it is more like a doctor reviewing his patient records, finding those that generate few income dollars for him and not seeing them any longer, only seeing those that come to him frequently and can be billed for extended vists and expensive procedures. The others can go see someone else. Atlex,
No it is more like a doctor reviewing his patient records, finding those that generate few income dollars for him and not seeing them any longer, only seeing those that come to him frequently and can be billed for extended vists and expensive procedures. The others can go see someone else.

]]> By: mole gerbil http://www.pharmalot.com/2009/10/vermont-gets-grilled-over-its-data-mining-law/#comment-437439 mole gerbil Thu, 15 Oct 2009 15:13:26 +0000 http://www.pharmalot.com/?p=19054#comment-437439 Ok.. Now I get why your employer will let you focus on Pharma-not-alot... this is going to be a subtle advertising vehicle for the PinkSh1t. I think you should just focus on the pinkie... it's not quite what it used to be. Ok.. Now I get why your employer will let you focus on Pharma-not-alot… this is going to be a subtle advertising vehicle for the PinkSh1t. I think you should just focus on the pinkie… it’s not quite what it used to be.

]]> By: atlex http://www.pharmalot.com/2009/10/vermont-gets-grilled-over-its-data-mining-law/#comment-437419 atlex Thu, 15 Oct 2009 11:34:19 +0000 http://www.pharmalot.com/?p=19054#comment-437419 Doc, there may be legitimate reasons to restrict the use of Rx data (although I don't buy them), but I'm not sure you've captured one. Any analogy to what you are saying would be to force doctors not to ask in advance what is wrong with patient so that they can schedule the proper amount of time for the appointment. Then every patient would get the same amount of time, no matter how serious or not the ailment is. That's a waste of resources and inefficient. By concentrating on high volume physician, all pharma is doing is optimizing resources. Doc, there may be legitimate reasons to restrict the use of Rx data (although I don’t buy them), but I’m not sure you’ve captured one. Any analogy to what you are saying would be to force doctors not to ask in advance what is wrong with patient so that they can schedule the proper amount of time for the appointment. Then every patient would get the same amount of time, no matter how serious or not the ailment is. That’s a waste of resources and inefficient. By concentrating on high volume physician, all pharma is doing is optimizing resources.

]]> By: Doc http://www.pharmalot.com/2009/10/vermont-gets-grilled-over-its-data-mining-law/#comment-437210 Doc Wed, 14 Oct 2009 20:32:41 +0000 http://www.pharmalot.com/?p=19054#comment-437210 Actually the use of Rx data by pharma essentially turns into a qui pro quo scenario. Marketing departments and sales reps armed with this data, disproportionately spend money (lunchs, snacks, breakfasts, etc) and give free samples to high volume MDs, often dropping lower volume MDs from their selling efforts. Sounds good except, if the knowledge that pharma thinks is so valuable for better patient care is not getting to a large percentage of low volume writers, what about their patients? By selectively giving most resources to high volume MDs, you are giving in order to get something in return, not something pharma is willing to do with low volume MDs. Call it what you like, but it stinks. All rx data should be restricted from pharma. Actually the use of Rx data by pharma essentially turns into a qui pro quo scenario. Marketing departments and sales reps armed with this data, disproportionately spend money (lunchs, snacks, breakfasts, etc) and give free samples to high volume MDs, often dropping lower volume MDs from their selling efforts.

Sounds good except, if the knowledge that pharma thinks is so valuable for better patient care is not getting to a large percentage of low volume writers, what about their patients?

By selectively giving most resources to high volume MDs, you are giving in order to get something in return, not something pharma is willing to do with low volume MDs.

Call it what you like, but it stinks. All rx data should be restricted from pharma.

]]>